Learn About Fertility Preservation X

PFC Infertility Doctor Blog

The Infertility Blog

November 12, 2013

In a brief video, Philip Chenette, MD, board certified reproductive endocrinologist at Pacific Fertility Center (PFC), describes how comprehensive chromosome screening (CCS) is changing the experience of in vitro fertilization (IVF) for PFC’s patients. Watch the video here.

San Francisco, CA – November 12, 2013 – A new genetic screening technique, Comprehensive Chromosome Screening (CCS) is producing very high pregnancy rates with low risks of miscarriage, multiple gestation, and Down syndrome, reports PFC’s Philip Chenette, MD. With the help of CCS, in fact, three out of four embryo transfers in 2012 resulted in a pregnancy at PFC—most with the transfer of only one embryo.

October 29, 2013

High pregnancy rates with minimum risk:
The new technology of CCS enables transfer of a single embryo while maintaining high pregnancy rates:

Building healthy families, one baby at a time, is our goal at Pacific Fertility Center.

Optimizing treatment outcomes is not just about high pregnancy rates. High success rates must be balanced by reducing risks. The goal is delivery of a healthy child in the fastest and lowest cost possible, while reducing risk of medical problems of pregnancy.

October 23, 2013

San Francisco, CA – October 23, 2013 – July 25th marked the 35th birthday of the world’s first “test tube baby” in the U.K. On the occasion of this significant landmark, the BBC recently visited Pacific Fertility Center (PFC) to get a glimpse of some of the more sophisticated assisted reproductive technologies that have emerged since that time.

October 17, 2013

Patient Case
KJ was 35 year-old when she presented to PFC after attempting to conceive with her partner for over 2 years. They conceived spontaneously after 14 months, but the baby did not have a heartbeat at the first ultrasound. She subsequently had a miscarriage. Her cycles were regular at 28 day intervals with increasingly heavier flow over the last several months. Her workup included a cycle day 3 follicle stimulating hormone (FSH) of 10 mIU/mL, antral follicle count (AFC) of 8, and an anti-mullerian hormone (AMH) of 0.5 ng/mL. Hysterosalpingogram (HSG, dye test to evaluate the fallopian tubes) revealed open tubes on both sides and a large uterine cavity filling defect. Preovulatory transvaginal ultrasound showed a 8mm endometrial lining whose trilaminar pattern was obscured by a 25mm submucosal fibroid. Semen analysis was normal.

October 10, 2013

We identify a problem with the sperm in about 30% of couples having infertility treatment. The issues range from having a low sperm count or motility, to having no sperm at all, or even to having sperm that are incapable of fertilizing eggs without significant intervention. The vast majority of these sperm problems can be solved by injecting a single sperm into each egg, using a technique called Intra Cytoplasmic Sperm Injection (ICSI). This works well for sperm with limitations such as poor motility or abnormal morphology (size and shape), and ICSI can be used in conjunction with chemical treatment of the egg in conditions such as gloobozoospermia (round headed sperm) where the sperm need a little help to complete the fertilization process.